Evidence map›Paper›PMID 21556147›Full record

ArticlePloS one2011

SDF1-induced antagonism of axonal repulsion requires multiple G-protein coupled signaling components that work in parallel.

E Naomi Twery, Jonathan A Raper

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. SDF1 reduces interneuron leading process branching through dual regulation of actin and microtubules.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  3. Article
  4. cAMP-induced expression of neuropilin1 promotes retinal axon crossing in the zebrafish optic chiasm.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

E Naomi TweryNeuroscience Graduate Group, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Jonathan A Raper

Funding

TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGYT32GM007229 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1985 to 2023
$14.0M
TRAINING PROGRAM IN DEVELOPMENTAL BIOLOGYT32HD007516 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI RAPER, JONATHAN A · 1998 to 2012
$5.6M
PURIFICATION OF PROTEINS THAT INHIBIT AXON EXTENSIONR01NS026527 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI RAPER, JONATHAN A · 1988 to 2007
$2.5M
Modulatory axonal guidance cuesR01DA025407 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI RAPER, JONATHAN A · 2008 to 2012
$2.1M
NICHD NIH HHS T32 HD007516NICHD NIH HHS T32HD007516NIDA NIH HHS R01 DA025407NIDA NIH HHS R01-DA025407NIGMS NIH HHS GM-7229-36NIGMS NIH HHS T32 GM007229NINDS NIH HHS R01 NS026527
6 · The paper itself

Abstract

SDF1 reduces the responsiveness of axonal growth cones to repellent guidance cues in a pertussis-toxin-sensitive, cAMP-dependent manner. Here, we show that SDF1's antirepellent effect can be blocked in embryonic chick dorsal root ganglia (DRGs) by expression of peptides or proteins inhibiting either Gα(i), Gα(q), or Gβγ. SDF1 antirepellent activity is also blocked by pharmacological inhibition of PLC, a common effector protein for Gα(q). We also show that SDF1 antirepellent activity can be mimicked by overexpression of constitutively active Gα(i), Gα(q), or Gα(s). These results suggest a model in which multiple G protein components cooperate to produce the cAMP levels required for SDF1 antirepellent activity.

Indexed as

AxonsSignal TransductionAnimalsChemokine CXCL12Chick EmbryoGTP-Binding ProteinsType C PhospholipasesChemokine CXCL12GTP-Binding ProteinsType C Phospholipases

Identifiers

PMID21556147
PMCPMC3083402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.